Yubo International Biotech Limited
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting ser… Read more
Market Cap & Net Worth: Yubo International Biotech Limited (YBGJ)
Yubo International Biotech Limited (PINK:YBGJ) has a market capitalization of $8.42 Million ($8.42 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #36701 globally and #11938 in its home market, demonstrating a 5.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yubo International Biotech Limited's stock price $0.05 by its total outstanding shares 170416343 (170.42 Million).
Yubo International Biotech Limited Market Cap History: 2020 to 2025
Yubo International Biotech Limited's market capitalization history from 2020 to 2025. Data shows change from $553.85 Million to $8.42 Million (-62.08% CAGR).
Yubo International Biotech Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yubo International Biotech Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4228.49x
Yubo International Biotech Limited's market cap is 4228.49 times its annual revenue
146.24x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $553.85 Million | $1.35 Million | -$711.80K | 409.09x | N/A |
| 2021 | $71.05 Million | $1.24 Million | -$1.54 Million | 57.09x | N/A |
| 2022 | $16.19 Million | $104.28K | -$1.20 Million | 155.25x | N/A |
| 2023 | $51.12 Million | $604.68K | -$1.20 Million | 84.55x | N/A |
| 2024 | $14.67 Million | $3.47K | -$1.78 Million | 4228.49x | N/A |
Competitor Companies of YBGJ by Market Capitalization
Companies near Yubo International Biotech Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Yubo International Biotech Limited by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
Yubo International Biotech Limited Historical Marketcap From 2020 to 2025
Between 2020 and today, Yubo International Biotech Limited's market cap moved from $553.85 Million to $ 8.42 Million, with a yearly change of -62.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.42 Million | -42.62% |
| 2024 | $14.67 Million | -71.30% |
| 2023 | $51.12 Million | +215.79% |
| 2022 | $16.19 Million | -77.21% |
| 2021 | $71.05 Million | -87.17% |
| 2020 | $553.85 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Yubo International Biotech Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.42 Million USD |
| MoneyControl | $8.42 Million USD |
| MarketWatch | $8.42 Million USD |
| marketcap.company | $8.42 Million USD |
| Reuters | $8.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.